Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.
Show tableHide table
| Period | Market cap |
|---|---|
| FY2016, ended Dec 31, 2016 | $25.7B |
| FY2017, ended Dec 31, 2017 | $25.2B |
| FY2018, ended Dec 31, 2018 | $26.7B |
| FY2019, ended Dec 31, 2019 | $28.8B |
| FY2020, ended Dec 31, 2020 | $24.3B |
| FY2021, ended Dec 31, 2021 | $31.7B |
| FY2022, ended Dec 31, 2022 | $40.1B |
| FY2023, ended Dec 31, 2023 | $42.4B |
| FY2024, ended Dec 31, 2024 | $66.0B |
| FY2025, ended Dec 31, 2025 | $73.4B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $90.9B |
Revenue
By fiscal year, then the trailing 12 months
Show tableHide table
| Period | Revenue |
|---|---|
| FY2016, ended Dec 31, 2016 | $7.50B |
| FY2017, ended Dec 31, 2017 | $8.03B |
| FY2018, ended Dec 31, 2018 | $8.69B |
| FY2019, ended Dec 31, 2019 | $8.20B |
| FY2020, ended Dec 31, 2020 | $7.72B |
| FY2021, ended Dec 31, 2021 | $12.8B |
| FY2022, ended Dec 31, 2022 | $17.8B |
| FY2023, ended Dec 31, 2023 | $12.0B |
| FY2024, ended Dec 31, 2024 | $12.6B |
| FY2025, ended Dec 31, 2025 | $14.9B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $15.4B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.
Show tableHide table
| Period | Net income | Free cash flow |
|---|---|---|
| FY2016, ended Dec 31, 2016 | −$424M | $2.10B |
| FY2017, ended Dec 31, 2017 | $2.17B | $690M |
| FY2018, ended Dec 31, 2018 | −$155M | $37.0M |
| FY2019, ended Dec 31, 2019 | $850M | $1.58B |
| FY2020, ended Dec 31, 2020 | $211M | $2.26B |
| FY2021, ended Dec 31, 2021 | $1.52B | $2.71B |
| FY2022, ended Dec 31, 2022 | $2.05B | $2.64B |
| FY2023, ended Dec 31, 2023 | $3.18B | $3.42B |
| FY2024, ended Dec 31, 2024 | $2.23B | $2.40B |
| FY2025, ended Dec 31, 2025 | $2.62B | $1.00B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $3.07B | −$108M |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2016, ended Dec 31, 2016 | $170M |
| FY2017, ended Dec 31, 2017 | $899M |
| FY2018, ended Dec 31, 2018 | $168M |
| FY2019, ended Dec 31, 2019 | $289M |
| FY2020, ended Dec 31, 2020 | $142M |
| FY2021, ended Dec 31, 2021 | $1.68B |
| FY2022, ended Dec 31, 2022 | $152M |
| FY2023, ended Dec 31, 2023 | $2.15B |
| FY2024, ended Dec 31, 2024 | $60.0M |
| FY2025, ended Dec 31, 2025 | $63.0M |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $203M |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.
Show tableHide table
| Period | Total debt |
|---|---|
| FY2016, ended Dec 31, 2016 | $23.5B |
| FY2017, ended Dec 31, 2017 | $20.9B |
| FY2018, ended Dec 31, 2018 | $22.4B |
| FY2019, ended Dec 31, 2019 | $22.3B |
| FY2020, ended Dec 31, 2020 | $22.3B |
| FY2021, ended Dec 31, 2021 | $23.7B |
| FY2022, ended Dec 31, 2022 | $22.9B |
| FY2023, ended Dec 31, 2023 | $26.4B |
| FY2024, ended Dec 31, 2024 | $26.9B |
| FY2025, ended Dec 31, 2025 | $29.4B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $30.8B |
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Up 48.1% since FY16.
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2016, ended Dec 31, 2016 | 826M |
| FY2017, ended Dec 31, 2017 | 827M |
| FY2018, ended Dec 31, 2018 | 1.21B |
| FY2019, ended Dec 31, 2019 | 1.21B |
| FY2020, ended Dec 31, 2020 | 1.21B |
| FY2021, ended Dec 31, 2021 | 1.22B |
| FY2022, ended Dec 31, 2022 | 1.22B |
| FY2023, ended Dec 31, 2023 | 1.22B |
| FY2024, ended Dec 31, 2024 | 1.22B |
| FY2025, ended Dec 31, 2025 | 1.22B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | 1.22B |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.
Show tableHide table
| Period | Bought back | Paid to employees | Sold for cash |
|---|---|---|---|
| FY2016, ended Dec 31, 2016 | — | $73.0M | $9.00M |
| FY2017, ended Dec 31, 2017 | — | $78.0M | $2.13B |
| FY2018, ended Dec 31, 2018 | — | $55.0M | $15.0M |
| FY2019, ended Dec 31, 2019 | — | $57.0M | $10.0M |
| FY2020, ended Dec 31, 2020 | — | $52.0M | $9.00M |
| FY2021, ended Dec 31, 2021 | $0 | $81.0M | $9.00M |
| FY2022, ended Dec 31, 2022 | $9.00M | $73.0M | $54.0M |
| FY2023, ended Dec 31, 2023 | $130M | $77.0M | $6.00M |
| FY2024, ended Dec 31, 2024 | $0 | $99.0M | $10.0M |
| FY2025, ended Dec 31, 2025 | $0 | $93.0M | $9.00M |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | — | $83.0M | $12.0M |
Valuation
At current price- Market Cap
- $90.6B
- P/E
- 29.5×
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 5.9×
- Price / Book
- 6.9×
- EV / EBITDA
- 17.3×
Growth
Trailing 12 months- Revenue (TTM)
- $15.4B
- Revenue Growth YoY
- 10.1%
- Revenue CAGR 3Y
- −5.7%
- Revenue CAGR 5Y
- 14.1%
- EPS Growth YoY
- 26.1%
- Net Income Growth YoY
- 26.5%
Profitability
Trailing 12 months- Gross Margin
- —
- Operating Margin
- 30.2%
- Net Margin
- 19.9%
- FCF Margin
- −0.7%
- Return on Equity
- 24.0%
Earnings
Trailing 12 months- Net Income
- $3.07B
- EPS (diluted)
- $2.51
- EBITDA
- $6.99B
- Operating Income
- $4.66B
Balance Sheet
As of Jun 30, 2026- Cash and cash equivalents
- $203M
- Total Debt
- $30.8B
- Net Debt
- $30.6B
- Total Assets
- $60.6B
- Total Liabilities
- $45.2B
- Shareholders' Equity
- $13.2B
Cash Flow
Trailing 12 months- Operating Cash Flow
- $5.99B
- Capital Expenditure
- $6.10B
- Free Cash Flow
- −$108M
Dividends and risk
Last 12 months- Dividend Yield
- 2.8%
- Dividend / Share
- $2.08
- Beta (5Y)
- 0.64
Every ratio is calculated from the company’s reported figures.